NCT07082777Active, not recruiting
Recovery in Telling Life Stories
Recovery in Telling Life Stories (RETELL): Testing a Narrative Identity Intervention for Personal Recovery in Individuals With Severe Mental Illness
Source: ClinicalTrials.gov · Last updated 4 Jun 2026
Brief summary (registry, in English)
This project tests the Recovery In Telling Life Stories (RETELL) intervention, aimed at supporting personal recovery in people with severe mental illness (SMI). While many of those with SMI experience symptom control, their quality of life often remains low due to social loss, negative self-perceptions, and identity-related challenges not addressed by standard treatments. Through a process of narrative repair, the RETELL intervention helps participants explore the personal consequences of mental illness while supporting the enhancement of narratives that strengthen identity and foster well-being. The intervention is delivered across 8-12 sessions and will be assessed for feasibility of both the intervention and study procedures. We will also explore its preliminary impact on recovery, quality of life, symptoms, functioning, self-stigma, and personality, using a multiple single-case A-B-A design. We expect the intervention and study procedures to show acceptable feasibility. We further hypothesize that participants' scores on recovery and well-being will be low at baseline, improve during the intervention, and remain higher after the intervention ends and at 3-month follow-up. This study will provide a foundation for future randomized controlled trials.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 4 Jul 2025
- Start date
- 21 Jul 2025
- Primary completion date
- 1 Apr 2027
- Lead sponsor
- University of Aarhus
- Diseases
- Schizophrenia, Bipolar disorder, Autism
- NCT number
- NCT07082777
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 21 Jul 2025 to the primary completion date, 1 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior conviction of violent crime
Other illness
- Self-reported diagnosis of mental retardation (F70-79) and/or organic mental disorder (F00-09)
- Psychiatric symptoms, thoughts of self-harm and/or substance abuse of self-reported severity which are likely to prevent one or all of the following: attendance at scheduled sessions, completion of questionnaires before, during and after the intervention, meaningful engagement in the therapeutic process
- Psychiatric hospitalization in the past 4 weeks
Other
- Currently homeless
- Currently in psychotherapy initiated within the past 6 months.
Who the study is looking for
- Adults between the ages of 18 and 65 years
- A self-reported principal diagnosis of one or more of the following: schizophrenia (F20), bipolar disorder (F31), personality disorders (F60), obsessive-compulsive disorder (F42), anxiety disorders (F41), recurrent depressive disorder (F33), eating disorders (F50), hyperkinetic disorders (F90), post-traumatic stress disorder (F43.1), Asperger syndrome (F84.5)
- Not in full recovery (Brief INSPIRE-O \< 50)
- Danish language proficiency
- Medication stabilized (i.e., same type and dosage for a minimum of 8 weeks)
- Ability and willingness to give informed consent
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aarhus Univerity Coordinator of this site? Confirm its status | Aarhus C | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.